Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Learn what to look for in no fee cashback card comparisons. Make informed choices to maximize your financial benefits.
15,402 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Investors are turning to international dividend stocks to lift income and reduce reliance on U.S. mega-caps. A $350,0...
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...
OpenAI leads the 2026 IPO chatter, with Stripe and Consensys jockeying for position as investors weigh odds, valuatio...
A broad pullback in semiconductors gave way to a cautious rally for Sandisk. This article breaks down what sparked th...
A looming 2027 COLA could lift benefits by billions, but inflation momentum and policy hurdles threaten social securi...
Parents often wrestle with whether to buy new or used for a teen gift. This article analyzes how a used Bronco wrappe...
Chris Jericho is partnering with Kokopi Koalas to co-create official traits for the Solana-based NFT collection, with...
A small group of everyday investors rode space-data trends to multimillion-dollar gains years before a SpaceX IPO hea...
AMD has sprinted ahead in a rapid rally. This guide weighs whether the late advanced micro devices story still offers...
If SpaceX goes public, investors will chase big headlines and big moves. History suggests year-one volatility is the ...
A federal class-action in Colorado expands as new homeowners join the suit against Unison. Plaintiffs allege Unison's...